Clinical Trials Directory

Trials / Completed

CompletedNCT05826106

The Benefits of R Anastomotic Technique for Billroth-Ⅱ Reconstruction With Braun Anastomosis After Totally Laparoscopic Distal Gastrectomy

R Anastomosis for B-Ⅱ-B Anastomosis

Status
Completed
Phase
Study type
Observational
Enrollment
85 (actual)
Sponsor
Northern Jiangsu People's Hospital · Academic / Other
Sex
All
Age
35 Years – 80 Years
Healthy volunteers
Not accepted

Summary

This study proposes a novel, straightforward, and viable technique for performing posterior gastrojejunostomy anastomosis during totally laparoscopic Billroth-II reconstruction with Braun anastomosis (named R anastomosis). This study prospectively evaluated clinical and pathological data from patients who underwent totally laparoscopic distal gastrectomy with R anastomosis at Northern Jiangsu People's Hospital, China, in order to investigate the feasibility and functional outcomes of R anastomosis for B-II-B anastomosis.

Detailed description

Paients were recruited who were confirmed to have malignant tumors in the gastric antrum or body through endoscopic and pathological examinations, and multi-slice spiral CT scans revealed no distant metastasis. All case underwent totally laparoscopic distal gastrectomy with R anastomosis. Prospectively examined the intraoperative data, including operation time, time for R anastomosis, blood loss; Postoperative data including pathological data, duration of gastric tube placement, time to initiate liquid diet, the length of hospital stay; other functional outcomes and short-term postoperative complication data, graded according to the Clavien-Dindo complication classification system

Conditions

Interventions

TypeNameDescription
PROCEDURER anastomosisModifying the surgical technique of totally laparoscopic Billroth-II reconstruction with Braun anastomosis and to name it as the R anastomosis.

Timeline

Start date
2019-03-01
Primary completion
2022-09-01
Completion
2023-03-01
First posted
2023-04-24
Last updated
2023-04-24

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT05826106. Inclusion in this directory is not an endorsement.